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Background: Some Ficus species have been used in traditional African medicine in the treatment of diabetes. The
antidiabetic potential of certain species has been confirmed in vivo but the mechanism of activity remains
uncertain. The aim of this study was to determine the activity and to investigate the mechanism of antidiabetic
activity of ten selected Ficus species through inhibition of α-amylase and α-glucosidase activity, and the possible
relationship between these activities, the total polyphenolic content and the antioxidant activity.
Methods: Dried acetone leaf extracts were reconstituted with appropriate solvents and used to determine total
polyphenolic content antioxidant activity, α-amylase and α-glucosidase inhibitory activity.
Results: The crude acetone extract of F. lutea had the highest polyphenolic content (56.85 ± 1.82 mg GAE/g of dry
material) and the strongest antioxidant activity with a TEAC value of 4.80 ± 0.90. The antioxidant activity of the
acetone extracts of the Ficus species may not be ascribed to total polyphenolic content alone. The crude extract at
a concentration of 0.5 mg/ml of F. lutea (64.3 ± 3.6%) had the best α-glucosidase (sucrase) inhibitory activity. The
EC50 of F. lutea (290 ± 111 μg/ml) was not significantly different from that of F. sycomorus (217 ± 69 μg/ml). The
α-amylase inhibitory activity of F. lutea (95.4 ± 1.2%) at a concentration of 1 mg/ml was the highest among the
Ficus species screened. The EC50 for F. lutea (9.42 ± 2.01 μ g/ml), though the highest, was not significantly different
(p < 0.05) from that of F. craterostoma and F. natalensis. It was apparent that the crude acetone extract of F. lutea is
a partially non-competitive inhibitor of α-amylase and α-glucosidase. Based on correlation coefficients polyphenolics
may be responsible for α-glucosidase activity but probably not for α-amylase activity.
Conclusion: Antidiabetic activity potential via inhibition of α-amylase and α-glucosidase was discovered in Ficus
lutea which has not been previously reported. The acetone extract of the leaves was high in total polyphenolic
content and antioxidant activity, and was a potent inhibitor of α-amylase activity. Research is underway to isolate
the active compound(s) responsible for the antidiabetic activity and to confirm the in vitro antidiabetic activity and
to investigate in vitro toxicity.
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Diabetes mellitus is an endocrine disease characterised by
chronic hyperglycaemia with the disturbance of carbohy-
drate, fat and protein metabolism resulting from defects
in insulin secretion, insulin action or both [1], and is typic-
ally associated with the failure of pancreatic β-cells. There
are two major types of diabetes mellitus - type 1 and type
2. In type 1 diabetes, or insulin dependent diabetes melli-
tus, the body has little or no insulin secretory capacity and
depends on exogenous insulin to prevent metabolic disor-
ders and death. In type 2 diabetes, a non-insulin depen-
dent diabetes mellitus, the body retains some endogenous
insulin secretory capability; however, their insulin levels
are low relative to their blood glucose levels and/or there
is a measure of insulin resistance. Type 2 diabetes is the
most prevalent form of the disease, accounting for 90-95%
of cases [2,3].
Obesity, a sedentary lifestyle and a diet high in carbo-
hydrate and fats are known risk factors for type 2 dia-
betes [4]. Globally, 171 million people were diagnosed
with the disease in 2000, and it has been predicted that
the prevalence will grow to 366 million by 2030 if no
intervention action is taken [5]. In sub-Saharan Africa
the disease is also considered to be an important emer-
ging disease partly due to changes in diet and lifestyle of
the people (a highly refined diet coupled to reduced
physical activity). This is brought about by westerniza-
tion, urbanization and mechanization, i.e. the disease
which was once associated with only the affluent has
increased in prevalence from 1% to 20% while in South
Africa it is 4% to 6% [3,6,7].
The prolonged hyperglycaemia that results in diabetic
patients has been speculated to induce oxidative stress
through the excessive generation of free radicals which
may impair endogenous antioxidant defence [8]. The
stabilization of blood glucose in diabetic patients is
therefore important to prevent these hyperglycaemic
complications [9]. The main therapeutic approach used
to achieve this objective in the diabetic patient is to
stimulate insulin release, increase the number of glucose
transporters, inhibit gluconeogenesis or reduce the ab-
sorption of glucose [10]. Another therapeutic approach
is to decrease the post-prandial hyperglycaemia [11],
which is achieved with the enzyme inhibitors such as
acarbose, voglibose and miglitol [12], which function by
retarding the action of the gastrointestinal carbohydrate
hydrolysing enzymes α-amylase and α-glucosidase. As a
result, these substances delay carbohydrate digestion
thereby decreasing the rate of glucose absorption, i.e.
they blunt the post-prandial plasma glucose rise [13].
While effective, the gastrointestinal side effects of acar-
bose, which includes bloating, abdominal discomfort,
diarrhoea, and flatulence make them less attractive as
therapeutic agents. New anti-diabetic compounds whichfunction by this mechanism but devoid of side effect are
therefore desirable [12,14].
Ficus is a genus of about 800 species of woody trees,
shrubs and vines in the family Moraceae. They are found
in all tropical habitat types, with about 100 species occur-
ring in Africa and the surrounding islands [15]. Several
species of the genus Ficus are used traditionally in a wide
variety of ethnomedical remedies all over the world
[16,17]. They have long been used in folk medicine as
antidiabetic, anthelmintic, hypotensive, mild laxative, anti-
rheumatic, digestive and anti-dysentery drugs [18,19].
From previous studies, these plants are known to have
chemical constituents such as triterpenes, sterols, poly-
phenols, flavonoids, coumarins, alkaloids and other me-
tabolites [20]. Polyphenolics are among the naturally
occurring antidiabetic agents [21], which may function via
various biological effects, of which one is the inhibition of
hydrolysing enzymes [22]. Polyphenolic compounds are
also one of the major constituents of medicinal com-
pounds which act as free radical scavengers and antioxi-
dants. Free radicals can react with biological molecules,
leading to cell and tissue injuries and pathological events.
Therefore the discovery of polyphenolic compounds with
a potential to inhibit the activity of digestive enzymes and
having excellent antioxidant activity with low adverse ef-
fects is important for the treatment of diabetes.
Twelve Ficus species have antidiabetic activity with
glucose lowering activity in alloxan or streptozotocin in-
duced diabetic laboratory animals. These are Ficus
benghalensis L. [23], Ficus carica L. [24], Ficus racemosa
L. [25], Ficus hispida L.f. [26], Ficus microcarpa L.f. [27],
Ficus religiosa L. [28], Ficus thonningii Blume [29], Ficus
glumosa Delile. [30] Ficus arnottiana (Miq.)Miq. [31],
Ficus glomerata Roxb. [32], F. sycomorus L. [33] and F.
deltoidea Jack [34]. Several Ficus species are also used
traditionally to treat diabetes and other ailments
(Table 1). Four of the Ficus species used in the current
study have in vivo blood glucose lowering potential
(Table 2). With the mechanism(s) of action being un-
known, we investigate the α-amylase and α-glucosidase
enzymes inhibitory activity of the acetone extracts of the
leaves of the ten Ficus species (Table 1). Acetone was se-
lected as extractant because it dissolves many hydro-
philic and lipophilic components from plants [48], it is
volatile and has low toxicity for use in bioassays [49].
Furthermore acetone does not extract sugars, which if
present (as would be the case with water and alcoholic




Dimethyl sulphoxide (DMSO), acetone, methanol and
Whatman No. 1 filter paper were purchased from Merck
Table 1 Previous reports on the traditional uses of the selected Ficus species *F. religiosa is a naturalized exotic
from China
Species Section Sub-section Parts used Uses Reference
F. capreifolia Delile
(sandpaper fig)
sycidium - Leaf, root Infections, vulnerary schistosomiasis [35]
F. cordata Thunb.
(Namaqua rock fig)
urostigma urostigma Bark stem Treatment of diarrhoea, tuberculosis [36]
F. craterostoma Mildbr.
& Burret. (forest fig)
galoglychia chlamydodorae leaves Treatment of stomach ache [37]
F. glumosa Delile
(hair rock fig)
galoglychia platyphyllae Leaves, stem/bark Treatment of skin diseases, diabetes, [30,38]
F. lutea Vahl.
(giant-leaves fig)
galoglychia galoglychia Leaves, bark Treatment of sores, boils, madness, rabies [39,40]
F. natalensis Hochst.
(coastal strangler fig)
galoglychia chlamydodorae Leaf, fruits, bark Treatment of skin infections, colic, venereal diseases [18,38,41]
F. polita Vahl.
(heart-leaved fig)
galoglychia caulocarpae Leaves, fruits, bark,
root




(bo tree or sacred fig)





sycomorus sycomorus Stem/bark, leaves,
root,
Treatment of tumours, inflammation, mental madness,




galoglychia chlamydodorae Leaves, fruits Bronchitis, urinary tract infection, epilepsy, diabetes [41,47]
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dium carbonate (Na2CO3), potassium persulphate, ABTS
[2, 2–azinobis-(3- ethylbenzothiazoline-6-sulfonic acid)],
potato starch, porcine pancreatic α- amylase enzyme
(type VI), sodium chloride, sodium phosphate, 3, 5-
dinitrosalicylic acid (DNS), sodium potassium tartrate,
sodium hydroxide, acarbose, rat intestinal acetone powder,
potassium phosphate, sucrose, TRIS (hydroxymethyl)
aminomethane, hydrogen chloride (HCl), the glucose oxi-
dase kit (GAGO 20) and Trolox (a synthetic water soluble
vitamin E analogue) were sourced from Sigma (South
Africa). The absorbance measurements were read using a
microtitre plate reader (Versamax, Molecular Devices).
Plant material
The leaves of ten Ficus species were collected at the
Manie van der Schijff Botanical Garden (University of
Pretoria), South Africa in February 2009, and voucher
specimens were conserved in the HGWJ Schweikerdt
Herbarium of the University of Pretoria. The names ofTable 2 Ficus species demonstrated to have blood
glucose lowering potential in vivo





Ficus glumosa stem/bark methanol 65 [30]
Ficus religiosa bark water 50 and 100 [28]
Ficus sycomorus Stem/bark methanol 250 [33]
Ficus thonningii stem/bark ethanol 120 and 240 [29]plant species and voucher numbers are as follow: Ficus
capreifolia Delile - PRU 33124; Ficus cordata Thunb -
PRU 35501; Ficus craterostoma Warb. ex Mildbr. &
Burret.- PRU 48293; Ficus glumosa Delile - PRU 38554,
Ficus lutea Vahl.- PRU 074568; Ficus natalensis Hochst -
PRU 078082; Ficus polita Vahl - PRU 35945; Ficus
religiosa L. - PRU 115415; Ficus sycomorus L. - PRU
066173; and Ficus thonningii Blume - PRU 57036. The
leaves were separated from the stems and dried at room
temperature. The dried plant materials were milled to a
fine powder in a Macsalab mill (Model 200 LAB, Eriez®
Bramley) and stored at room temperature in closed glass
bottles in the dark until extracted.
Preparation of plant extracts
The powdered plant material (2 g) was extracted with
acetone (20 ml) in polyester centrifuge tubes using a
shaker (Labotec model 20.2) at room temperature for
30 min. The extracts were centrifuged and filtered
through Whatman No. 1 filter paper. This procedure
was repeated three times on the same plant material to
ensure that all possible compounds were extracted. The
filtered extracts of each species were transferred into
pre-weighed glass vials and solvent was left to evaporate
at room temperature under a stream of cold air. The
percentage yield was expressed on the air-dried mass of
the leaves. The dried crude acetone extracts obtained
were dissolved in appropriate solvent and used for ana-
lyses of total polyphenolics, antioxidant activity and
in vitro α-amylase and α-glucosidase inhibition.
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The amount of total polyphenolics was determined using
the method described by Djeridane et al. [51]. This
method depends on the reduction of Folin-Ciocalteu re-
agent (a 2 N phosphomolybdic-phosphotungstic reagent)
by phenols to a mixture of blue oxides. The commercial
reagent was diluted 10-fold with double-distilled water.
A standard curve was developed using gallic acid. Diffe-
rent concentrations of gallic acid were prepared in 80%
methanol in a 96-well microtitre plate, and their absorb-
ance immediately recorded at 760 nm. The crude ace-
tone extracts were dissolved in 80% methanol to a final
concentration of 1 mg/ml. The plant extract (100 μl
of the 1 mg/ml) was dissolved in 500 μl (1/10 dilution)
of the Folin-Ciocalteu reagent. After the addition of
1000 μl of distilled water the mixture was allowed to
stand for 1 min at room temperature, where after
1500 μl of a 20% Na2CO3 solution was added. The final
mixture was shaken, followed by an incubation period of
1 h in the dark at room temperature. The absorbance of
all samples was measured at 760 nm. All analyses were
performed in triplicate and repeated three times. The re-
sults are expressed in mg of gallic acid equivalent (GAE)
per gram of dry weight of plant material.
Trolox equivalent anti-oxidant capacity (TEAC)
The total antioxidant activity was estimated using the
Trolox equivalent capacity (TEAC) test [52]. In this assay,
the relative capacity of antioxidant to scavenge the ABTS +
[2, 2–azinobis- (3-ethylbenzothiazoline-6-sulfonic acid)]
radical compared to the antioxidant potency of Trolox (6–
hydroxyl–2,5,7,8-tetramethlchromane-2-carboxylic acid), a
synthetic water soluble vitamin E analogue, was measured.
The ABTS + radical was produced by reacting 7 mM
ABTS aqueous solution with 2.4 mM potassium
persulphate in the dark for 12–16 h at room temperature.
Prior to assay, the pre- formed ABTS + radical was diluted
in methanol (about 1:89 v/v) and equilibrated to give an
initial absorbance (Ai) of 0.700 (±0.02) at 734 nm. The
crude acetone extracts were made up in methanol to a
concentration of 0.0625 mg/ml to 1 mg/ml and the Trolox
was made up to a concentration of 0.0625 mg/ml to
0.5 mg/ml in methanol. The crude acetone extract or
Trolox standard (20 μl) was added to the ABTS + radical
(180 μl) and the mixture allowed to react for 6 minutes,
and the absorbance (A) read at 734 nm in a spectropho-
tometer at one- minute intervals. Appropriate solvent
blanks were included in each assay. The percentage
change in absorbance was calculated for each concentra-
tion of extracts and Trolox. To calculate the TEAC, the
gradient of the plot of the percentage inhibition of absorb-
ance versus concentration plot for the extract under inves-
tigation is divided by the gradient of the plot for Trolox
[52]. As a result, the TEAC of a substance is a ratio valueand has no unit. All assays were carried out in triplicate
and repeated three times. The percentage change in ab-
sorbance (A) was measured as follows;
% change in A ¼ Ai ABTS
þ 734 nmð Þ−New mean A ABTSþ
Ai ABTS




An adapted α-amylase inhibition assay as described by Ali
et al. [50] was utilised. The dried crude acetone extracts
were re-dissolved in DMSO to a concentration of 20 mg/
ml and used for the α-amylase inhibition assay. Ice cold
porcine pancreatic α-amylase solution (200 μl) at 4 unit/ml
(type VI) was pre-incubated with 40 μl of crude acetone
extracts and 160 μl of distilled water, and mixed in a
screw-top plastic tube. The reaction was started by the
addition of 400 μl of potato starch (0.5%, w/v) in 20 mM
phosphate buffer (pH 6.9) containing 6.7 mM sodium
chloride, and thereafter incubated at 25°C for 3 min. Final
concentrations in the incubation mixture were plant ex-
tract (1 mg/ml), 0.25% (w/v) starch and 1 unit/ml enzyme.
An aliquot of the mixture (200 μl) was removed and placed
into a separate tube containing 100 μl DNS colour reagent
solution (96 mM 3, 5-dinitrosalicylic acid, 5.31 M sodium
potassium tartrate in 2 M NaOH) and placed into an 85°C
water bath. After 15 min, this mixture was removed from
the water bath, cooled and diluted with 900 μl distilled
water. α-Amylase activity was determined by measuring
the remaining starch content by measuring the absorbance
of the mixture at 540 nm. Control incubations, repre-
senting 100% enzyme activity were conducted by replacing
the plant extract with DMSO (40 μl). For the blanks (nega-
tive controls) the enzyme solution was replaced with dis-
tilled water and the same procedure was carried out as
above. Acarbose was used as positive control (acarbose
1 mg/ml: α-amylase 1 unit/ml). The α-amylase inhib-
ition activity was expressed as;





α- Glucosidase inhibition assay
A commercial rat intestine acetone powder was pur-
chased and used to prepare enzyme solution according
to the method of Oki et al. [53] with slight modifica-
tions. In brief, rat intestinal acetone powder (25 mg/ml)
was homogenized in ice-cold 50 mM phosphate buffer.
After centrifugation at 6 000 × g for 15 min, the clear
supernatant obtained was used as the enzyme solution
for determining α-glucosidase activity.
Table 3 Percentage yield, total polyphenol content and
antioxidant activity of crude acetone extracts of leaves of
ten Ficus species
Species Yield (%) aTotal polyphenol
(mg GAE/g dry weight)
abAntioxidant
activityTEAC
Ficus capreifolia 2.32 4.73 ± 0.26c 0.34 ± 0.05c
Ficus cordata 2.65 8.23 ± 1.00d 0.27 ± 0.03c
Ficus craterostoma 2.60 9.80 ± 0.93d 0.66 ± 0.06d
Ficus glumosa 2.60 19.24 ± 0.79e 1.29 ± 0.30e
Ficus lutea 3.70 56.85 ± 1.82f 4.80 ± 0.90f
Ficus natalensis 2.35 4.75 ± 0.92c 0.69 ± 0.08d
Ficus polita 3.15 8.04 ± 0.52d 0.31 ± 0.06c
Ficus religiosa 2.45 5.40 ± 0.35c 0.59 ± 0.18c
Ficus sycomorus 2.60 12.33 ± 0.26e 1.91 ± 0.19e
Ficus thonningii 2.40 4.64 ± 0.48c 0.77 ± 0.06d
aValues are means of triplicate determinations done three times (n = 9) ±
standard error;
bAntioxidant activity (Trolox equivalent antioxidant capacity).
c,d,e,fNo significant difference between extracts with same value, but significant
difference p<0.05 between different values.
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mined using the method of Bhandari et al. [54], with a
slight modification. Sucrose (200 μl of a 56 mM solu-
tion) in 0.1 M potassium phosphate buffer (pH 7) was
mixed with 100 μl of crude acetone extracts (2.5 mg/ml)
in 50% aqueous dimethyl sulphoxide (DMSO) in a test
tube. After pre-incubation at 37°C for 5 min, 200 μl of
rat intestinal α-glucosidase solution prepared as de-
scribed above was added. Whereas 100 μl DMSO (50%)
was used in place of the plant extract to represent 100%
enzyme activity, Acarbose (0.1 mg/ml) was used as the
positive control and for the blanks (negative controls)
the enzyme solution was replaced with distilled water
and the same procedure was carried out as above. Final
concentrations in the incubation mixture for plant ex-
tracts were 0.5 mg/ml and 0.02 mg/ml for acarbose.
After thoroughly mixing, the test sample, solvent and
positive control test tubes were incubated at 37°C for
20 min and then the reaction was stopped by adding
750 μl of 2 M Tris–HCl buffer (pH 6.9). The amount of
liberated glucose was determined by the glucose oxidase
method using a commercial test kit (Sigma GAGO 20)
according to the manufacturer’s instructions. The ab-
sorbance of the wells was measured at 540 nm and the
inhibitory activity was calculated using the following
formula:





Kinetics of inhibition against α- amylase and α- glucosidase
activities
The kinetics of inhibition of the crude acetone extract of
F. lutea against α- amylase and α- glucosidase activities
were measured by increasing substrate concentrations of
starch (0.016% - 0.5%) and sucrose (7 mM – 56 mM) re-
spectively in the absence and presence of extract of F.
lutea at concentrations of 25–100 μg/ml for α-amylase
inhibitory assay and 62.5 – 250 μg/ml for α- glucosidase
inhibitory assay. The type of inhibition was determined
by Lineweaver-Burk double reciprocal plot analysis of
the data, which was calculated from the result according
to Michaelis-Menten kinetics [11].
Calculation of EC50
A dose response effect was conducted on α- amylase
and α-glucosidase for the extracts. The concentrations
of extracts used ranged from 16 to 500 μg/ml. The con-
centration of extract that inhibited 50% of the enzyme
activity under assay conditions was defined as the effect-
ive concentration (EC50) and this was established usingthe programme Kinetica 5 (Thermo). The concentration
response relationship was plotted and fitted to a Hill’s
model. The model was described by the following equa-
tion; y ¼ ymaxx∝c∝þx∝ . The EC50 concentrations attained were
used for comparison of the potency of the various crude
acetone plant extracts.
Statistical analysis
All experiments were performed in triplicate and repeated
three times to yield nine dose- response curves. Data are
presented as the mean ± standard error of mean (S.E.M.).
Statistical significances were evaluated by one-way analysis
of variance (ANOVA) and student’s t-test, with post hoc
analysis using the Bonferroni corrected t-test. P-values less
than 0.05 were considered to be significant.
Results
Extraction of plant material
Ten Ficus species were selected on the basis of availabil-
ity and were extracted with acetone. In Table 3, the per-
centage yields of crude acetone extracts of the ten Ficus
species are reported. The percentage yield ranged from
2.32% to 3.70% among the leaf extracts where the extract
of F. lutea had the highest yield (3.70%), followed by
F. polita (3.15%). The extracts of F. natalensis (2.35%)
and F. capreifolia had the lowest yields (2.32%).
Total polyphenol content and antioxidant activity
The total polyphenol content of the crude acetone
extracts of the ten Ficus species has highly variable
(Table 3), with a range of 4.64 to 56.85 mg GAE/g dry
weight of plant. When the total polyphenol content of
Table 4 The percentage inhibition of α-amylase activity
(1 mg/ml) and concentration leading to 50% inhibition
(EC50) of crude acetone extracts of the ten selected Ficus
species
Species (%) α- amylase inhibitiona EC50 (μg/ml)
Ficus capreifolia 43.8 ± 3.3b >100
Ficus cordata 45.9 ± 5.2b > 100
Ficus craterostoma 48.3 ± 1.6b 11.41 ± 4.68b
Ficus glumosa 65.1 ± 3.0c > 100
Ficus lutea 95.4 ± 1.2d 9.42 ± 2.01b
Ficus natalensis 43.7 ± 1.8b 17.85 ± 4.42b
Ficus polita 40.2 ± 2.6b > 100
Ficus religiosa 35.3 ± 2.8b > 100
Ficus sycomorus 40.0 ± 2.8b > 100
Ficus thonningii 37.6 ± 2.7b > 100
Acarbose 96.7 ± 0.3 0.04 ± 0.03
a% α-amylase inhibitory activity of crude acetone extracts of ten South African
Ficus species (1 mg/ml) and control (acarbose) (0.04 mg/ml). Results expressed
as% mean ± SEM (n = 9). b,c,dNo significant difference between extracts with
same value, but significant difference p˂0.05 between different values.
Table 5 The percentage inhibition of α-glucosidase
activity (0.5 mg/ml) and concentration leading to 50%
inhibition (EC50) of crude acetone extracts of ten Ficus
species
Species (%) α-glucosidase inhibitiona EC50 (μg/ml)
Ficus capreifolia 24.3 ± 1.7b > 1000
Ficus cordata 22.0 ± 3.6b > 1000
Ficus craterostoma 28.2 ± 7.0b > 1000
Ficus glumosa 38.7 ± 6.5b > 1000
Ficus lutea 64.3 ± 3.6c 290 ± 111b
Ficus natalensis 23.6 ± 8.1b > 1000
Ficus polita 29.2 ± 5.8b > 1000
Ficus religiosa 17.6 ± 8.0b > 1000
Ficus sycomorus 35.7 ± 5.4b 217 ± 69b
Ficus thonningii 25.3 ± 5.0b > 1000
Acarbose 84.8 ± 1.7 3.4 ± 0.5
a% α-glucosidase inhibitory activity of crude acetone extracts of ten South
African Ficus species (0.5 mg/ml) and control (acarbose) (0.02 mg/ml). Results
expressed as % mean ± SEM (n = 9).
b,c.No significant difference between extracts with same value, but significant
difference p<0.05 between different values.
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(56.85 ± 1.82 mg/g) was found to have a remarkably
higher content (p˂0.001) followed in decreasing order
by extracts of F. glumosa and F. sycomorus with total poly-
phenol content of 19.24 ± 0.79 and 12.33 ± 0.26 mg GEA/g
dry weight of plant respectively. The extracts with the low-
est values in decreasing order were F. natalensis, F.
capreifolia and F. thonningii with total phenolic content of
4.75 ± 0.92, 4.73 ± 0.26 and 4.64 ± 0.28 mg GAE/g dry
weight of plant respectively.
The antioxidant activities of the extracts, expressed as
Trolox equivalent antioxidant capacity (TEAC) are listed
in Table 3. The crude acetone extracts of the ten Ficus
species had different antioxidant capacities (Table 3).
The total antioxidant activity for the ten Ficus species
varied widely from 4.80 ± 0.90 to 0.27 ± 0.03 TEAC
under the assay conditions. The antioxidant activity of
the extract of F. lutea (4.80 ± 0.90 TEAC) was signifi-
cantly different (p˂0.001) when compared with that of
the other extracts, followed by F. sycomorus and F.
glumosa in decreasing order with antioxidant activity of
1.91 ± 0.18 and 1.29 ± 0.30 TEAC respectively. The ex-
tracts with the lowest TEAC in decreasing order were F.
capreifolia, F. polita and F. cordata with 0.34 ± 0.05,
0.31 ± 0.06 and 0.27 ± 0.03 TEAC respectively. The cor-
relation coefficient between total polyphenolic content
and TEAC of the crude acetone extracts of the ten Ficus
species R2 was 0.50.
α-Amylase inhibitory activity of extracts of Ficus species
The inhibitory activity of the crude acetone extracts of
the ten Ficus species are presented in Table 4. The ex-
tract of F. lutea had the highest inhibitory potential with
activity of 95.4 ± 1.2% inhibition at 1 mg/ml. This was
followed by the extract of F. glumosa with 65.1 ± 3.0%
inhibition at the same concentration while Acarbose, the
positive control, had inhibitory activity of 96.7 ± 0.3% at
0.04 mg/ml. The extracts of the other Ficus species mod-
erately inhibited α-amylase with activity between 40%
and 45%, with the exception of the extracts of F.
religiosa and F. thonningii which had poor inhibitory ac-
tivities. The EC50s are presented in Table 4. The extract
of F. lutea was most potent (EC50 of 9.42 ± 2.01 μg/ml)
followed by F. craterostoma (EC50 = 11.41 ± 4.68 μg/ml)
and F. natalensis (EC50 = 17.85 ± 4.42 μg/ml) with no
significant difference present between them (p<0.05).
Acarbose was characterised by an EC50 of 0.04 ±
0.03 μg/ml. The correlation coefficient between total
polyphenolic content and inhibition of α-amylase activity
by the extracts of the ten Ficus species R2 was 0.65. Con-
versely, the correlation coefficient between antioxidant
activity (TEAC) and inhibition of α-amylase activity by
the crude acetone extracts of the ten Ficus species R2
was 0.41.α-Glucosidase inhibitory activity of extracts of Ficus
species
The crude acetone extracts of the ten Ficus species were
generally weak inhibitors of α- glucosidase activity
(Table 5), with only F. lutea demonstrating inhibitory ac-
tivity of 64.3 ± 3.6% at a concentration of 0.5 mg/ml
(Significantly different (p˂0.05) to the other extracts).
Acarbose (positive control) was a potent inhibitor of α-
glucosidase (84.8 ± 1.7%) at a concentration of 0.02 mg/
ml. The EC50s for the inhibitory activity is presented in
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with an EC50 of 217 ± 69 μg/ml, followed closely by the
extract of F. lutea (290 ± 111 μg/ml), with no significant
difference between them (p˂0.05). The EC50 of
Acarbose was 3.4 ± 0.5 μg/ml. The correlation coefficient
between total polyphenolic content and inhibition of α-
glucosidase activity by the crude acetone extracts of the
ten Ficus species R2 was 0.74. In addition, the correlation
coefficient between antioxidant activity (TEAC) and in-
hibition of α-glucosidase activity by the crude acetone
extracts of the ten Ficus species R2 was 0.67.The enzyme kinetics of α- amylase and α- glucosidase
inhibition by extract of F. lutea
Analysis of the α-amylase and α-glucosidase kinetics by the
crude acetone extract of F. lutea is shown in Figure 1. For
the α-amylase (Figure 1A) and α-glucosidase (Figure 1B)
inhibition by F. lutea, the intersection of the double recip-
rocal plot is seated at a point above the +1/[s] axis, indicat-
ing that F. lutea acts as a partially non-competitive-type
inhibitor of α-amylase and α- glucosidase.Figure 1 Lineweaver-Burk double reciprocal plots for kinetic
analysis of the reaction of porcine pancreatic α-amylase with
starch (%) used as substrate (A) and rat intestinal α-glucosidase
with sucrose (mM) used as substrate (B) in the absence and
presence of extract of F. lutea.Discussion
The most challenging goal in the management of type 2
diabetes mellitus is to achieve blood glucose levels as
close to normal as physiologically possible [55]. With
postprandial hyperglycaemia being the earliest metabolic
abnormality detectable, modulation of this rise is an im-
portant tool in the management of the diabetic patient
[56,57]. α-Amylases are endoglucanases, which hydrolyse
the internal α-1,4 glucosidic linkages in starch, and α-
glucosidase (sucrase), one of the glucosidases located in
the brush border surface membrane of intestinal cells, is
a key enzyme for carbohydrate digestion and absorption.
These enzymes have been recognized as therapeutic tar-
gets for modulation of postprandial hyperglycaemia. In
addition, prolonged hyperglycaemia is an independent
risk factor for the development of microvascular and
macrovascular complications of diabetes mellitus which
is mediated through oxidative stress [55,58].
In this study the inhibitory effectiveness of the acetone
extract of the leaves of ten Ficus species against the
α-amylase and α-glucosidase enzymes were evaluated.
As a secondary objective, the relationship between total
polyphenolic content and antioxidant activity was also
studied. For this study, a positive correlation between
total polyphenolic content and inhibition of α-amylase
and α-glucosidase activity was present with R2 values of
0.65 and 0.74 respectively. This therefore indicates the
likelihood of the polyphenols in the acetone extracts be-
ing partly responsible for the inhibition of the activity of
the enzymes. The latter was not an unexpected finding
as the polyphenolic extracts from a number of plants
have been previously shown to be effective inhibitors
of the intestinal α-glucosidase and α-amylase enzyme
systems [59].
The extracts of ten Ficus species were evaluated for
their potential to specifically inhibit activity of porcine
pancreatic α-amylase and rat small intestinal α-
glucosidase. The ten Ficus species were generally potent
inhibitors of activity of the porcine pancreatic α-amylase
but weak inhibitors of activity of the rat small intestinal
α-glucosidase. Three of the four Ficus species with
in vivo blood glucose lowering potential in previous
studies (Table 2) were all weak inhibitors of the activity
of α-amylase and α-glucosidase in vitro. While the rea-
son for the difference could be due to the different com-
pounds being extracted as a result of different solvents
used in these studies, the more likely reason was that
the glucose lowering potential of these plants may be
due to non-α-amylase or α-glucosidase inhibitory activ-
ities, such as the stimulation of glucose uptake, the
stimulation of insulin release or the inhibition of
gluconeogenesis.
The fourth Ficus species (F. sycomorus) which is used
traditionally by the Hausa and Fulani tribes of northern
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cose lowering potential in vivo (Table 2) was a weak
inhibitor of α-amylase activity but a potent inhibitor of
α-glucosidase (sucrase) activity with an EC50 of 217 ±
69 μg/ml. We therefore believe that the glucose lowering
potential demonstrated in vivo by the extract of F.
sycomorus may be due to the inhibition of α-glucosidase
activity (sucrase). Some authors have shown that the
extracts of other Ficus species such as F. racemose [60],
F. benghalensis [61] and F. deltoidea [62] inhibit the ac-
tivity of sucrase with an EC50 of 367 ± 15.2 μg/ml and
239 ± 14.3 μg/ml respectively for cold and hot water ex-
tract of F. racemosa, and 193 ± 21.6 μg/ml and 141 ±
22.1 μg/ml respectively for cold and hot water extract of
F. benghalensis. This was in agreement with our results.
Furthermore, studies also showed the activity of α-amylase
is inhibited with an EC50 of 0.94 ± 0.15% and 0.58 ± 0.15%
respectively for the cold and hot water extracts of
F. racemosa, [60] and, 4.4 and 125 μg/ml respectively for
the cold and hot water extracts of F. benghalensis [63], this
was also in agreement with our results.
Some studies have observed the potency with which
polyphenols inhibited the activity of porcine pancreatic
α-amylase and rat small intestinal α-glucosidase to be dif-
ferent [59,64]. Strawberry and raspberry extracts were the
most effective inhibitors of α-amylase followed by blue-
berry and blackcurrant. Although these extracts also
inhibited rat intestinal α- glucosidase activity, the order of
effectiveness was different than with α-amylase. Blueberry
and blackcurrant were the most effective followed by
strawberry and raspberry [59]. Rat intestinal α-glucosidase
is generally weakly inhibited by many flavonoids, while fla-
vonoids are often potent inhibitors of porcine pancreatic
α-amylase [64]. It is possible that the extracts of the Ficus
species used in this study demonstrated potent α-amylase
inhibitory activity because they contain more of the fla-
vonoid groups with the extract of F. lutea being the most
potent.
Polyphenolic compounds may also be indirectly bene-
ficial in disease by chelating metal ions [65] or activating
the expression of antioxidant enzymes [66] or directly
acting as antioxidants [67]. High total phenolic contents
may not always translate to a high antioxidant activity.
Pulido et al. [68] reported that antioxidant efficiency of
the polyphenols seemed to depend on the position and
extent of hydroxylation and conjugation. This was also
observed in this study where the correlation between
total polyphenolic content and antioxidant activity had
an R2 value of 0.5. We found that extracts of F. glumosa,
F. sycomorus and F. lutea had good antioxidant activities
and high total phenolic contents. Some authors have
shown that F. glumosa [30], F. sycomorus [69] and F. lutea
[39] have very good DPPH. scavenging activities with
reported IC50 of 79.5 ± 1.77 μg/ml and 11.9 ± 0.3 μg/mlrespectively for F. sycomorus and F. lutea, and this is in
agreement with our results. Among these three Ficus spe-
cies, the extract of F. lutea displayed the highest total
polyphenolic content and the highest antioxidant activity.
In addition, the qualitative phytochemical analysis con-
ducted (results not included) showed that tannin was one
of the prominent phytochemicals contained in the crude
acetone extract of F. lutea. Hagerman et al. [70] reported
that the high molecular weight polyphenols (tannins) have
the ability to quench free radicals (ABTS+) and their ef-
fectiveness depends on the molecular weight, the number
of aromatic rings and the nature of the hydroxyl group
substitutions. It is also possible that not all polyphenolic
compounds possess ABTS + radical scavenging activities
[71]. Free radical (ABTS+) scavenging of Ficus species may
be due to the presence of high molecular weight polyphe-
nols, such as catechins, pelargonidins and leucopelar-
gonidin derivatives in addition to the flavonoids [72]. A
study of the correlation between antioxidant activity and
inhibition of α-amylase and α-glucosidase activity by the
ten Ficus species had an R2 value of 0.41 and 0.67 re-
spectively indicating that the polyphenolic compounds
responsible for antioxidant activity may likely be re-
sponsible for the inhibition of α-glucosidase activity but
may not be responsible for the inhibition of α-amylase
activity. Some authors have demonstrated that com-
pounds with potent antioxidant activity are also strong
inhibitors of α-glucosidase activity.
When studying the kinetics of inhibition, the extract of
F. lutea showed partial non- competitive inhibition against
porcine pancreatic α-amylase and α-glucosidase. A fully
non- competitive inhibitor binds the enzyme substrate
[ES] complex, not the free enzyme and affects the break-
down of the [ES] to form a product. Likewise, a partial
non-competitive inhibitor binds to the enzyme-substrate
complex but it is assumed that the inhibitor is released
from the enzyme at the same time [ES] is broken down to
the product [73]. This type of inhibition does occur where
there are multiple inhibitors as will be the case for a crude
extract of F. lutea [73]. Another study demonstrated that
pure compounds such as D-xylose and (+)- catechin are
un-competitive inhibitors of rat intestinal α-glucosidase
activity [53].
The results of this study revealed that the crude acet-
one extract of F. lutea is high in total polyphenolic con-
tent and antioxidant activity, and is a potent inhibitor of
α-amylase activity. This in vitro study has demonstrated
that polyphenolic compounds present in F. lutea may
likely be responsible for the inhibitory activity against
the carbohydrate hydrolysing enzymes.
Conclusion
This study investigated the potential antidiabetic activity
of ten South African Ficus species, focussing on effects on
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activity. All acetone extracts of the ten Ficus species had
α-amylase and α-glucosidase enzyme inhibitory activity.
The crude acetone extract of F. lutea was the most active
in all the assays. This is the first report of the antidiabetic
potential of F. lutea in potentially lowering blood glucose
levels in vitro. The crude acetone extract of F. lutea was
more active in vitro than the crude acetone extracts of the
three Ficus species that are reported to be used tradition-
ally to treat diabetes. The activity that is responsible for
the antidiabetic activity appears to reside in the polar frac-
tion of the extract of F. lutea, so rural people should be
able to extract the active compound(s) with water or alco-
hol. Research is underway to isolate the active compound
responsible for the antidiabetic activity, to confirm the
in vitro antidiabetic activity, and to investigate toxicity and
efficacy in vivo.
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